Create
Query
event_store.db
—
signals
actions
approvals
artifacts
commitments
constraints
conversation_compaction
conversation_state
conversation_turns
dead_letters
decisions
deliveries
effects
email_messages
email_reply_drafts
email_threads
entities
entity_aliases
entity_tags
episode_context_index
episodes
event_subjects
events
events_archive
fact_sources
facts
inbox_items
inbox_links
jobs
leader_leases
links
memory_candidates
memory_embeddings
memory_items
memory_items_fts
(v)
memory_items_fts_config
memory_items_fts_data
memory_items_fts_idx
opportunity_memory
pending_interactions
proposal_sources
proposals
reminders
schedules
schema_migrations
signal_candidates
signal_fps
signals
sms_conversations
sms_messages
sms_reply_drafts
source_cursors
sources
sqlite_sequence
sqlite_stat1
stream_cursors
threads
watchers
Toggle helper tables
memory_items_fts_content
memory_items_fts_docsize
memory_items_fts_segdir
memory_items_fts_segments
memory_items_fts_stat
Structure
Content
Query
Insert
Drop
Import
Export
Update row sig_5061624d5a88 in signals
id
sig_5061624d5a88
Primary key.
TEXT
event_id
21607
TEXT NOT NULL
watcher_id
NULL
TEXT
signal_type
discovery_sec_filing_delta
TEXT NOT NULL
value
{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001193125-26-151209.txt","as_of":"2026-04-11T03:10:51.104915+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001193125-26-151209.txt","company":"Vir Biotechnology, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001193125-26-151209.txt","article_chars":1823,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_1c021890cf6fa484","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001193125-26-151209.txt","content_type":"text/plain","enriched_at":"2026-04-11T05:10:11.033992+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"8-K","final_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001193125-26-151209.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001193125-26-151209.txt","source_event_id":"evt_86b93c4e4b61","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"8-K","fp":"77105b356efb9d91","kind":"sec_filing","published_at":"20260410","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-07","2026-04-24","2026-04-11"],"entities":[{"asset_class":"equity","name":"Vir Biotechnology, Inc.","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"person","name":"Mark Eisner, MD, MPH","relevance":"high","symbol":"","type":"person"},{"asset_class":"equity","name":"Vir Biotechnology, Inc. (the Company)","relevance":"medium","symbol":"","type":"issuer"}],"event_type":"other","information_gaps":["No prior known state is provided in the signal, so the exact change vs prior disclosure cannot be determined.","The filing\u2019s SEC \u201cDate of Report (Date of earliest event reported)\u201d field is not populated in the cleaned text, so the earliest-event date is not explicitly confirmed from the article text.","No details are provided about whether Eisner\u2019s departure is voluntary or involuntary, whether there are transition arrangements, or any compensatory arrangements.","No successor name or timing for appointment is disclosed in the provided text."],"key_facts":["Form type: 8-K (Current Report).","Item 5.02 is disclosed: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","On April 7, 2026, Mark Eisner, MD, MPH (Executive Vice President and Chief Medical Officer), informed the Company he will step down.","Eisner\u2019s stepping down is effective April 24, 2026.","The Company initiated a search for Eisner\u2019s successor."],"numeric_claims":[{"label":"Effective date of stepping down","value":"2026-04-24"},{"label":"Date Eisner informed the Company","value":"2026-04-07"}],"primary_claim":"Mark Eisner will step down as Vir\u2019s Executive Vice President and Chief Medical Officer effective April 24, 2026, per the company\u2019s April 7, 2026 notice.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"Vir Biotechnology, Inc. filed a Form 8-K reporting that Mark Eisner, MD, MPH, will step down as Executive Vice President and Chief Medical Officer effective April 24, 2026, and the company has initiated a search for a successor.","topics":["SEC filing","Form 8-K","executive officer departure","director/officer transition","succession search"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 8-K \u00b7 Vir Biotechnology, Inc. \u00b7 Filed 20260410","ticker":"VIR","tickers":["VIR"],"title":"VIR filed 8-K","url":"https://www.sec.gov/Archives/edgar/data/1706431/0001193125-26-151209.txt"}
TEXT NOT NULL
threshold
NULL
TEXT
direction
NULL
TEXT
severity
NULL
TEXT
window
NULL
TEXT
source
discovery_sec_filings
TEXT NOT NULL
reason_trace
{"_evidence_event_ids":["evt_86b93c4e4b61"]}
TEXT
dedupe_key
signal_enriched:discovery_sec_filing_delta:58f6592fa3b2b78b
TEXT NOT NULL
throttle_s
INTEGER (default 0
created_at
2026-04-11T03:10:51.104915+00:00
TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')
Update
Cancel